Opportunities for in vivo imaging in non-clinical safety studies

被引：0
|
作者：
Stephan-Gueldner, M. [1 ]
Buergin, H. [2 ]
Funk, J. [2 ]
Grimm, H. P. [2 ]
Sanders, M. [2 ]
Zabka, T. S. [2 ]
Singer, T. [2 ]
Bergstroem, M. [2 ]
机构：
[1] F Hoffmann La Roche & Cie AG, Basel, Switzerland
[2] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, CH-4002 Basel, Switzerland
来源：
TOXICOLOGY LETTERS | 2011年 / 205卷
关键词：
D O I：
10.1016/j.toxlet.2011.05.097
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [31] Editorial: in vitro and in vivo non-clinical models of kidney cancers
    Dormoy, Valerian
    Filhol, Odile
    Sourbier, Carole
    Massfelder, Thierry
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Arrhythmogenic liability screening in cardiovascular safety pharmacology: Commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies
    Authier, Simon
    Pugsley, Michael K.
    Troncy, Eric
    Curtis, Michael J.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2010, 62 (02) : 83 - 88
  • [33] Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
    Hebar, Alexandra
    Koller, Christiane
    Seifert, Jan-Marcus
    Chabicovsky, Monika
    Bodenteich, Angelika
    Bernkop-Schnuerch, Andreas
    Grassauer, Andreas
    Prieschl-Grassauer, Eva
    PLOS ONE, 2015, 10 (04):
  • [34] Designing non-clinical safety evaluation programmes: The view of the clinician
    Lipani, J
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 1 - 6
  • [35] Non-clinical Safety Assessment of Angiotensin 1-7
    Thun, S.
    Petersen, K. U.
    Christoph, T.
    Schmitz, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S79 - S79
  • [36] Use of minipigs in non-clinical juvenile toxicology studies
    Makin, Andrew
    Skytte, Christina
    Grand, Nanna
    TOXICOLOGY, 2010, 278 (03) : 373 - 374
  • [37] Safety Behaviours, Rumination and Trait Paranoia in a Non-Clinical Sample
    Simpson, Jennifer
    MacGregor, Bryony
    Cavanagh, Kate
    Dudley, Robert E. J.
    JOURNAL OF EXPERIMENTAL PSYCHOPATHOLOGY, 2012, 3 (04): : 612 - 623
  • [38] Points to consider on the non-clinical safety evaluation of anticancer drugs
    Nakae, Dai
    Onodera, Horoshi
    Fueki, Osamu
    Urano, Tsutomu
    Komiyama, Noriyuki
    Sagami, Fumio
    Kai, Shuichi
    Nishimura, Chihiro
    Inoue, Tohru
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02): : 123 - 126
  • [39] Designing non-clinical safety evaluation programmes: The view of the toxicologist
    Dempster, M
    SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 7 - 15
  • [40] An overview of non-clinical safety studies in current Turkish regulations for the development of COVID-19 vaccines
    Ozdem, Sadi S.
    BIOLOGICALS, 2022, 75 : 1 - 2
12345